Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • European Journal of Endocrinology Prize Lecture
  • • Cortisol and cardiovascular disease

      ea0014eje1
    • European Journal of Endocrinology Prize Lecture

      ea0014eje1biog
  • Geoffrey Harris Prize Lecture
  • • Neuroendocrine control of steroid biosynthesis within the hypothalamus

      ea0014gh1
    • Geoffrey Harris Prize Lecture

      ea0014gh1biog
• Plenary Lectures
• • Reading beyond the sequence – the plasticity of the LH/CG-LH receptor system
  • • Reading beyond the sequence- the plasticity of the LH/CG-LH receptor system

      ea0014pl1
  • Reciprocal regulations of bone and energy metabolisms
  • • Reciprocal regulations of bone and energy metabolisms

      ea0014pl2
  • Importance of transporters for cellular entry of thyroid hormone
  • • Importance of transporters for cellular entry of thyroid hormone

      ea0014pl3
  • Metabolic syndrome: a cultural exercise or clinical entity?
  • • The metabolic syndrome: a cultural exercise or a clinical entity?

      ea0014pl4
  • The coordination of circadian time in brain and peripheral organs
  • • The coordination of circadian timing in brain and peripheral organs

      ea0014pl5
  • Initial work-up & long term follow-up in patients with pheochromocytomas & paragangliomas
  • • Initial work-up and long term follow-up in patients with pheochromocytomas and paragangliomas

      ea0014pl6
  • Nuclear receptors: from molecular mechanisms to biological functions
  • • Nuclear receptors: from molecular mechanisms to biological functions

      ea0014pl7
• Symposia
• • Hypopituitarism
  • • Traumatic brain injury-induced hypopituitarism: whom and when to test

      ea0014s1.1
    • Morbidity and mortality

      ea0014s1.2
    • Hypocorticotropism

      ea0014s1.3
    • Familial neurogenic diabetes insipidus

      ea0014s1.4
  • Hormones and the brain
  • • Thyroid hormone regulation of neural and oligodendrocyte precursors in the mature brain: a possibility for remyelination and neuroprotection

      ea0014s2.1
    • Neuroprotective actions of estrogens in the central nervous system

      ea0014s2.2
    • Estrogen receptor signalling and cerebrovascular disease

      ea0014s2.3
    • Immunesenescence and steroid hormones

      ea0014s2.4
  • Signaling and regulation of G-protein-coupled hormone receptors
  • • Trafficking and signaling of angiotensin receptors

      ea0014s3.1
    • Pharmacological chaperones rescue the membrane expression and function of a mutant of the vasopressin V1b/V3 receptor

      ea0014s3.2
    • Functional impact of GPCR heterodimerzation

      ea0014s3.3
    • Ago-allosteric effects of agonist drugs on 7TM receptors and their endogenous hormones – example from the ghrelin receptor

      ea0014s3.4
  • Gastroenteropancreatic endocrine tumors
  • • Pathological classification of GEP neuroendocrine tumors

      ea0014s4.1
    • Biological, morphological work-up and screening for inherited disease

      ea0014s4.2
    • Prognosis of GEP ET

      ea0014s4.3
    • Therapeutic management of GEP ET

      ea0014s4.4
  • Novel bioactive peptides – lessons from animals
  • • Discovery of novel bioactive peptides: the uniquely important contribution of amphibians to mammalian neuropeptidology

      ea0014s5.1
    • Comparative approaches to resolve the complexities of human appetite regulation

      ea0014s5.2
    • Bioactive peptides in invertebrate model organisms

      ea0014s5.3
    • Somatostatin, cortistatin and their new and old receptors: from comparative to translational endocrinology

      ea0014s5.4
  • Diabetes and insulin
  • • Perspectives of islet cell transplantations

      ea0014s6.1
    • Cytokines as pathogenetic effectors in type 1 and type 2 diabetes

      ea0014s6.2
    • GLP-1 as a drug target

      ea0014s6.3
    • Engineering beta cells to recover insulin function

      ea0014s6.4
  • Thyroid cell biology
  • • New insights from zebrafish: the molecular and cellular base of thyroid development

      ea0014s7.1
    • Involvement of cardiovascular development and non-cell autonomous signaling in mouse thyroid organogenesis

      ea0014s7.2
    • Thyroglobulin deposition and cathepsin-dependent Tg mobilization

      ea0014s7.3
    • Role of the complex Megalin-RAP in thyroglobulin trafficking

      ea0014s7.4
  • Advances in adrenal hypersecretory disorders
  • • Autocrine-paracrine pathways in primary adrenal disorders

      ea0014s8.1
    • Carney complex and primary pigmented nodular adrenocortical diasease

      ea0014s8.2
    • Diagnosis of primary aldosteronism

      ea0014s8.3
    • Adrenocortical carcinoma: current and future therapeutic options

      ea0014s8.4
  • Imaging in endocrinology
  • • PET in diagnostics of metabolic alterations and endocrinological tumours

      ea0014s9.1
    • Macro-, micro-, and molecular imaging of bone

      ea0014s9.2
    • New tracers for neuroendocrine tumors

      ea0014s9.3
    • Echoendoscopy for the diagnosis of pancreatic endocrine tumors

      ea0014s9.4
  • GH and prolactin at their targets
  • • Cellular control mechanisms for GH sensitivity

      ea0014s10.1
    • GH receptor signalling

      ea0014s10.2
    • Gene expression profiling of the antiangiogenic factor 16K human prolactin (hPRL) on endothelial cells underlines the key role of NF-κB and reveals novel mechanisms of action

      ea0014s10.3
    • Development of human prolactin receptor antagonists

      ea0014s10.4
  • Polycystic ovary syndrome
  • • The CAG repeat polymorphism of the androgen receptor gene is an independent risk factor for polycystic ovary syndrome (PCOS)

      ea0014s11.1
    • Genetic markers of polycystic ovary syndrome (PCOS)

      ea0014s11.2
    • Hyperandrogenism and metabolic syndrome (MBS) in polycystic ovary syndrome (PCOS)

      ea0014s11.3
    • Individual pharmacological therapy for polycystic ovary syndrome: lessons from the phenotype

      ea0014s11.4
  • Hypothalamic network controlling food intake
  • • Processing of metabolic signals in the hypothalamus: the integrative role of the paraventricular nucleus

      ea0014s12.1
    • Neurotransmitter content of orexigenic and anorexigenic neurones

      ea0014s12.2
    • The picture of the hypothalamus is becoming clearer: new concept of cross-talk

      ea0014s12.3
    • Whom is insulin in the brain speaking to?

      ea0014s12.4
  • Glucocorticosteroids
  • • Recent developments in nuclear receptor action

      ea0014s13.1
    • Evaluation of steroid receptor function by gene targeting in mice

      ea0014s13.2
    • The 11β-hydroxysteroid dehydrogenase story

      ea0014s13.3
    • Glucocorticoid sensitivity: consequences for the clinic?

      ea0014s13.4
  • Trojan horses for steroids
  • • Alpha-fetoprotein protects the developing female brain from estrogens

      ea0014s14.1
    • Role of endocytic receptors in cellular uptake of steroid hormones

      ea0014s14.2
    • Hepatic deiodinase activity is dispensable for the maintenance of normal thyroid hormone levels in mice

      ea0014s14.3
    • IGF-independent actions of IGFBPs

      ea0014s14.4
  • Novel bone hormones and regulators
  • • Sclerostin, an osteocyte-produced regulator of bone formation

      ea0014s15.1
    • Hormonal regulation of periosteal bone growth

      ea0014s15.2
    • Wnt signaling and LRP 5/6 regulation of bone mass

      ea0014s15.3
    • Thyroid hormones/TR and bone

      ea0014s15.4
  • Immune-endocrine turmoil of pregnancy
  • • Endocrine diseases during pregnancy

      ea0014s16.1
    • Estetrol (E4), the forgotten fetal steroid

      ea0014s16.2
    • Regulatory T cells in pregnancy

      ea0014s16.3
    • The effect of pregnancy on immune disease

      ea0014s16.4
  • Somatostatin receptors in health and disease
  • • Pro and contra of SRIF analogue therapy in pituitary tumors

      ea0014s17.1
    • Somatostatin receptors in neuroendocrine tumors

      ea0014s17.2
    • Peptide receptor therapy

      ea0014s17.3
    • Cortistatin, a multi-functional somatostatin receptor analog

      ea0014s17.4
  • Puberty and hypogonadism
  • • Endocrine disorders of puberty

      ea0014s18.1
    • Role of sex steroids and nitric oxide in male sexual function

      ea0014s18.2
    • Clinical management of premature ovarian failure

      ea0014s18.3
    • Gonadal function in ageing men

      ea0014s18.4
  • Pituitary cell biology
  • • Role of folliculo-stellate cells in the anterior pituitary: a historical review

      ea0014s19.1
    • Signalling in pituitary tumours: the roles of Akt, BRAF, AIP and other novel agents

      ea0014s19.2
    • Oncogene gsp and Gsα overexpression in pituitary cell biology

      ea0014s19.3
    • Adipocytokines and pituitary function

      ea0014s19.4
  • Thyroid
  • • Updated guidelines for the follow-up of thyroid cancer.

      ea0014s20.1
    • Congenital hypothyroidism with gland in situ

      ea0014s20.2
    • Thyroid and ageing

      ea0014s20.3
    • Thyroid autoimmunity: genes and environment

      ea0014s20.4
  • Pheromones, odorant and taste receptors
  • • Odorant receptors and reproduction

      ea0014s21.1
    • Molecular architecture of pheromone sensing in mammals

      ea0014s21.2
    • Endocrine and behavioural responses to pheromones

      ea0014s21.3
    • Bitter taste receptors and food intake

      ea0014s21.4
  • Bone
  • • Bisphosphonates: molecular mode of action and adverse effects

      ea0014s22.1
    • Calcimimetics in the management of hyperparathyroidism

      ea0014s22.2
    • Primary hyperparathyroidism: surgical approach and benefits

      ea0014s22.3
    • Absolute risk prediction for fracture

      ea0014s22.4
  • Reproductive endocrinology/andrology
  • • Androgen regulation of spermatogenesis

      ea0014s23.1
    • The experimental mouse model for men with Klinefelter syndrome

      ea0014s23.2
    • Genes involved in male infertility: sorting facts from fiction

      ea0014s23.3
    • Genetic basis of testicular tumors

      ea0014s23.4
  • Obesity
  • • Altering adipocyte metabolism as a way to counteract obesity and insulin Resistance

      ea0014s24.1
    • Triglyceride-lowering effect of metabolic switch in white adipose tissue

      ea0014s24.2
    • Adipokines and insulin sensitivity in humans

      ea0014s24.3
    • Lipodistrophy and abdominal fat accumulation: new therapeutic alternatives

      ea0014s24.4
  • Novel hormones
  • • Hormones help you live longer - the threat of Klotho

      ea0014s25.1
    • Phosphatonins and the regulation of renal phosphate transport

      ea0014s25.2
    • Correlation of desoxypyridinolin and c– terminal telopeptide of collagen type I within different patient collectives

      ea0014s25.3
    • Hormonal regulation of iron homeostasis by hepcidin

      ea0014s25.4
• Meet the Expert Sessions
• • (1)
  • • Endocrine orbitopathy

      ea0014me1
    • Mineralocorticoid hypertension

      ea0014me2
    • Fetal programming by androgen excess

      ea0014me3
    • Intensive insulin treatment in ICU

      ea0014me4
    • Hirsutism

      ea0014me5
    • Differential diagnosis of hypercortisolism

      ea0014me6
    • Endocrine disrupting chemicals: an emerging threat to public health?

      ea0014me7
    • Mass Spectrometry in endocrinology

      ea0014me8
    • Turner Syndrome (TS)

      ea0014me9
    • Indications, management and follow up of bariatric surgery

      ea0014me10
    • Thyroid echocolordoppler

      ea0014me11
    • Stem cell therapy in endocrinology: reality and challenges

      ea0014me12
• Oral Communications
• • Thyroid clinical
  • • Prevalence of inactivating TSH receptor (TSHR) mutations in a large series of pediatric subjects with non-autoimmune mild hyper-thyrotropinemia (hyperTSH)

      ea0014oc1.1
    • Expression gene profile may be useful for the diagnosis of thyroid malignancies

      ea0014oc1.2
    • Persistence of decreased peripheral B-lymphocytes after Rituximab treatment is associated to inactive disease in patients with thyroid-associated ophthalmopathy

      ea0014oc1.3
    • A novel tyrosine-kinases selective inhibitor with anti-tumoral efficacy (Sunitinib) induces a block in iodine uptake and transient hypothyroidism

      ea0014oc1.4
    • CTLA- 4 gene polymorphisms and autoimmune thyroid diseases: meta-analyses of published and individual-level data

      ea0014oc1.5
    • Sensitization against Soybean may induce an increase in the levels of anti-thyroid peroxidase antibodies in thyroid autoimmunity

      ea0014oc1.6
    • Pregnant women on thyroxine substitution are often dysregulated in early pregnancy

      ea0014oc1.7
  • Bone & calcium metabolism
  • • Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis

      ea0014oc2.1
    • Role of IGF system on the regulation of osteoblast aromatase activity in vitro

      ea0014oc2.2
    • Clinical and biochemical differences in patients affected with sporadic and type 1 multiple endocrine neoplasia (MEN) related primary hyperparathyroidism

      ea0014oc2.3
    • Assessment of prevalent vertebral deformities in morphometric X-ray absorptiometry

      ea0014oc2.4
    • Effect of gonadal status on baseline and after rhGH treatment prevalence of spinal deformities in adult patients with growth hormone deficiency (GHD)

      ea0014oc2.5
    • Sunlight exposure and vitamin D supplementation at the institutionalized elderly – effects on calcium and bone metabolism

      ea0014oc2.6
    • Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells

      ea0014oc2.7
  • Endocrine tumors & neoplasia
  • • Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion

      ea0014oc3.1
    • Adrenal lesions in multiple endocrine neoplasia type 1: data from the French Group for the Study of Endocrine Tumors (GTE)

      ea0014oc3.2
    • BMP dependent effects on adrenal tumorigenesis and function

      ea0014oc3.3
    • RET mutation – Tyr791Phe – the genetic cause of different diseases derived from neural crest

      ea0014oc3.4
    • [¹²³I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience

      ea0014oc3.5
    • ERß-specific transcriptional profile in colon cancer

      ea0014oc3.6
    • Fasting insulin levels are predictors of colonic lesions in patients with acromegaly: an observational, open, prospective study in 189 patients

      ea0014oc3.7
  • Neuroendocriology basis
  • • Organismal, cellular and molecular evolution of water balance regulation in vertebrates: the amphibian hinge

      ea0014oc4.1
    • Growth Hormone-Releasing Hormone (GHRH) exerts protective effects on adult rat hippocampal progenitor cells

      ea0014oc4.2
    • Absence of germline AIP mutations in early onset sporadic somatotropinomas

      ea0014oc4.3
    • Is there a role for dopamine D₂ receptor gene polymorphisms in determining cabergoline sensitivity in prolactin-secreting pituitary adenomas?

      ea0014oc4.4
    • Lack of nuclear Hes1 expression coincides with transformation of endocrine pancreatic cells in Men1 knock out mice

      ea0014oc4.5
    • Metabolic abnormalities in patients with adrenal adenomas may be associated with BclI polymorphism in the glucocorticoid receptor (GR) gene and expression of tumor-specific hsp70 isoforms

      ea0014oc4.6
    • Function and evolution of GHRH, PACAP and PRP in vertebrates

      ea0014oc4.7
  • Thyroid basic
  • • Structure-function of glycoprotein hormones using site-directed mutagenesis and gene transfer: designing new agonists and antagonists

      ea0014oc5.1
    • Tyroglobulin (Tg) depletion in receptor associated protein (RAP) KO mice is due to a reduction of Tg aggregates

      ea0014oc5.2
    • Polarized plasma membrane targeting of the Na⁺/I⁻ symporter (NIS) is regulated by its carboxy terminus

      ea0014oc5.3
    • BRAF^V600E mutations but not RET/PTC rearrangements are correlated with a lower expression of NIS mRNA expression in papillary thyroid cancer (PTC)

      ea0014oc5.4
    • Transcriptional regulation of human type 2 deiodinase and chorionic gonadotropin genes in human placenta: emerging evidence of a common promoter code

      ea0014oc5.5
    • A crucial role of interleukin-6 in the pathogenisis of thyrotoxicosis-related disturbances of bone turnover in mice

      ea0014oc5.6
    • The 1188A/C polymorphism of IL-12 gene in Graves’ disease

      ea0014oc5.7
  • Cardiovascular endocrinology
  • • Growth hormone-releasing hormone prevents cardiomyocyte apoptosis and activated PI3K/AKT, ERK1/2 and CREB signaling pathways

      ea0014oc6.1
    • Testosterone replacement attenuates fatty streak formation and improves the HDLC profile in the Tfm mouse: an effect which is independent of the classical androgen receptor

      ea0014oc6.2
    • Plasma brain natriuretic peptide (BNP) levels predict acute right ventricular dysfunction in pulmonary embolism – prospective study on 70 patients

      ea0014oc6.3
    • Carotid IMT and stiffness, aortic stiffness and pulse pressure: association with hormone therapy in postmenopausal women: baseline findings from the CASHMERE trial

      ea0014oc6.4
    • Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression in mononuclear blood cells: a randomized trial in healthy men

      ea0014oc6.5
    • The importance of the TAAAA(n) alleles at the SHBG gene promoter for the severity of cardiovascular disease in women

      ea0014oc6.6
    • Evaluation of tolvaptan, an oral vasopressin V2 receptor antagonist, in ‘asymptomatic’ hyponatremia: effects on sodium concentration and patient reported health outcomes

      ea0014oc6.7
  • Reproductive endocrinology I
  • • Kallmann syndrome: mutations in the genes encoding prokineticin-2 (PROK2) and prokineticin receptor-2 (PROKR2)

      ea0014oc7.1
    • Neuropilin-2 and its ligands are involved in the migration of GnRH-secreting neurons

      ea0014oc7.2
    • Gonadotrophins regulate germ cell survival, not proliferation, in normal adult men

      ea0014oc7.3
    • Capacitation and acrosome reaction in human ejaculated spermatozoa involve activation of a novel SRC tyrosine kinase

      ea0014oc7.4
    • Estrogens regulate epididymal contractility through RhoA/Rho-kinase signaling

      ea0014oc7.5
    • Serum anti-Müllerian hormone levels in men with normo- and oligozoospermia

      ea0014oc7.6
    • Use of atorvastatin, but not simvastatin in men with Type 2 diabetes is associated with lower total testosterone levels with no effect on bioavailable or free testosterone

      ea0014oc7.7
  • Neuroendocrinology clinical
  • • Growth hormone response during OGTT: the impact of assay method, gender and BMI on the estimation of reference values in patients with acromegaly and in healthy controls

      ea0014oc8.1
    • Effect of GH receptor antagonist pegvisomant on cardiovascular risk and atherosclerosis in acromegalic patients resistant to somatostatin analogues

      ea0014oc8.2
    • Pituitary imaging abnormalities in patients with and without hypopituitarism after traumatic brain injury

      ea0014oc8.3
    • Idiopathic central hypothyroidism: report of a human natural model of congenital TRH receptor (TRHR) absence

      ea0014oc8.4
    • Inoperable pituitary tumours treated with ⁹⁰Y-DOTA-TATE – initial results

      ea0014oc8.5
    • Improved glucocorticoid replacement therapy by a novel oral hydrocortisone modified-release tablet

      ea0014oc8.6
    • A single intravenous bolus of dexamethasone for the diagnosis of Cushing’s syndrome

      ea0014oc8.7
  • Signal transduction
  • • Investigation of the role of MRAP in the functional expression of the melanocortin 2 receptor

      ea0014oc9.1
    • The human orexin receptor type 2 gene: Alternative promoters determining tissue-specific expression and identification of alternate splice variants and altered translational activities

      ea0014oc9.2
    • Orexin-A inhibits glucagon secretion and proglucagon gene expression

      ea0014oc9.3
    • Signalling and internalisation properties of corticotrophin-releasing hormone (CRH) receptor type 2

      ea0014oc9.4
    • The third intracellular loop of human SST5 is crucial for receptor internalization after SS28 stimulation

      ea0014oc9.5
    • Somatostatin receptor subtype-2 and -3 – selective agonists inhibit insulin secretion from INS-1 cells through modulation of the R-type Ca²⁺ channel

      ea0014oc9.6
    • Seven transmembrane receptors mediated actin cytoskeleton rearrangement: comparison with constitutively active mutants of G protein alpha-subunits

      ea0014oc9.7
  • Obesity & metabolism
  • • The selective neuronal deletion of cannabinoid type 1 receptor is still able to provide resistance to diet-induced obesity

      ea0014oc10.1
    • 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) mRNA expression in liver of patients with non-alcoholic steatohepatitis

      ea0014oc10.2
    • Selective leptin resistance within the brainstem of histamine deficient mice

      ea0014oc10.3
    • Restoration of signalling capabilities in total loss of function MC4R mutations

      ea0014oc10.4
    • Mice lacking CRF receptor type 1 (CRFR1) have reduced vulnerability to diet-induced obesity

      ea0014oc10.5
    • 3-Iodothyronamine (T1AM) is a novel modulator of metabolic rate and glucose homeostasis

      ea0014oc10.6
    • Serum level of retinol binding protein 4 in obese individuals with insulin resistance and with type 2 diabetes mellitus treated by metformin

      ea0014oc10.7
  • Reproductive endocrinology II
  • • Hypogonadotrophic hypogonadism in mice lacking a functional Kiss-1 gene

      ea0014oc11.1
    • Leukemia inhibitory factor promotes the chemomigration of immature GnRH neurons

      ea0014oc11.2
    • Sex steroid and leptin regulation of KISS1/GPR54 system, a new regulator of the neuroendocrine reproductive axis, in human fetal GnRH-secreting neurons

      ea0014oc11.3
    • EGFR ligands mediate key events of female reproduction: reduced litter size due to impaired fertilization in a transgenic mouse model

      ea0014oc11.4
    • Integration of the EGF network with early LH signal in preovulatory follicles

      ea0014oc11.5
    • Visceral fat amount as predictor for subclinical cardiovascular disease in women with polycystic ovary syndrome

      ea0014oc11.6
    • The current definitions of the metabolic syndrome underestimate the prevalence of nascent metabolic abnormality in adolescents with PCOS

      ea0014oc11.7
  • Diabetes
  • • Hypoglycemia and cerebral ATP synthesis in Type 1 Diabetes

      ea0014oc12.1
    • Uncoupling protein 2 mutations – a new explanation for congenital hyperinsulinism?

      ea0014oc12.2
    • Adhesion molecules two years after gestational diabetes

      ea0014oc12.3
    • Polymorphisms of PSMA6 gene and its adjacent genomic sites and their association with type II diabetes mellitus in the Latvian population

      ea0014oc12.4
    • The influence of concomitant diabetes mellitus on mortality in Addison’s disease

      ea0014oc12.5
    • Short-term effects of atorvastatin on endothelial functions and oxidized LDL levels in type 2 diabetic patients

      ea0014oc12.6
    • A propensity-based comparison of haemodialysis and peritoneal dialysis among diabetic patients with end-stage renal disease in the United States

      ea0014oc12.7
• Poster Presentations
• • (1)
  • • Human adrenal NCI-H295R cells produce more C19 steroids than NCI-H295A cells – a possible model to study regulation of androgen biosynthesis?

      ea0014p1
    • Effects of ethanol and blokade of synthesis of nitric oxide on level of ACTH in female rats

      ea0014p2
    • Study of the hypothalamic-pituitary-adrenal axis in patients with the antiphospholipid syndrome

      ea0014p3
    • Survey of thyroid function of Hungarian Vizsla population in Hungary

      ea0014p4
    • Pancreatic polypeptide (PP) radioimmunoassay in acute phase and regression of cerulein induced pancreatitis

      ea0014p5
    • Evaluation of neuroendocrine disfunction in hypothalamo-pituitary-adrenal axis in diagnosis of depressive and non-depressive alcohol-dependent persons

      ea0014p6
    • Effects of melatonin on glutathione peroxidase activity after adriamycin in normal and pinealectomized rats

      ea0014p7
    • Is there any role for anti-inflammatory cytokine Interleukin-10 in advanced congestive heart failure?

      ea0014p8
    • Regulation of GAGEC1, a cancer-testis associated antigen family member, by sex steroid hormones and TGF-beta: implications for prostatic disease

      ea0014p9
    • Normalization of serum testosterone level alters local GnRH-II and IL-2R mRNA expression in peripheral lymphocytes in patients with idiopathic hypogonadotrophic hypogonadism (IHH)

      ea0014p10
    • Blocking undesired leptin action in vivo with leptin antagonists prepared by site-directed mutagenesis of human, ovine, rat and mouse leptin site III

      ea0014p11
    • Role of soluble Fas-antigen (sFas), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in adrenocortical carcinoma patients

      ea0014p12
    • Rosiglitazone interferes with the inflammatory response induced in human endothelial cells by TNFalpha and IFNgamma through a new mechanism involving extracellular signal-regulated kinases (ERKs)

      ea0014p13
    • Role of growth hormone/insulin like growth factor 1 system in the remodelling process of the right ventricle in top levels rowers

      ea0014p14
    • Clinical significance of simultaneously determined serum interleukin-6, dehydroepiandrosterone and its sulphate levels in melanoma

      ea0014p15
    • Changes in growth hormone messenger RNA (GHmRNA) expression in rats anterior pituitary after single Interferon (IFN)alpha administration.

      ea0014p16
    • Does stress test influence Interleukin (IL)-2 and IL-8 concentration in serum patients with stable ischaemic heart disease?

      ea0014p17
    • Concentration of inflammatory factors such as CRP (acute phase response protein) and Interleukin (IL)-6 in serum patients with stable ischemic heart disease during trimetazidine treatment

      ea0014p18
    • Insulin decreases IGF-I bioactivity in patients with impaired glucose tolerance and in healthy subjects

      ea0014p19
    • Plasma free fatty acids and adipocytokines concentration in relation to insulin sensitivity in patients with anorexia nervosa.

      ea0014p20
    • Improved glucose metabolism and altered pancreatic structure in transgenic mice overexpressing betacellulin

      ea0014p21
    • Screening of 120 adipokines in subcutaneous adipose tissue of patients with growth hormone deficiency reveals changed protein levels

      ea0014p22
    • Human somatotrophic (GH) adenoma cells – interleukin (IL)-1β induces production of il-6 and il-8.

      ea0014p23
    • Serum ferritin concentrations in an impaired fasting glucose population and their normal control group

      ea0014p24
    • Implications of serum resistin in overweight diabetic patients with ischemic heart disease

      ea0014p25
    • The protective effect of tribulus terrestris in diabetes

      ea0014p26
    • Prevalence of I27L polymorphism of hepatic nuclear factor-1[alpha] in diabetic patients younger than 35 years old.

      ea0014p27
    • Novel mechanism of chronic exposure of oleic acid-induced insulin release impairment in rat pancreatic β-cells

      ea0014p28
    • Quality of care in a diabetic outpatient clinic

      ea0014p29
    • Cardiovascular risk factors (CVRF) as predictors of microalbuminuria (MA) in type 2 diabetes mellitus (T2DM) patients

      ea0014p30
    • The prevalence of metabolic syndrome and its relation to metabolic control in patients with diagnosed type 2 diabetes

      ea0014p31
    • Effects of rosiglitazone (RGZ) and pioglitazone (PGZ) on serum androgens and urinary steroid profile in patients with type 2 diabetes: A prospective, randomised cross-over study

      ea0014p32
    • Abnormal glucose challenge test reflects mild gestational diabetes

      ea0014p33
    • Ambulatory blood pressure reduction after rosiglitazone treatment in normotensive type 2 diabetic patients

      ea0014p34
    • Time dependent effects of rosiglitazone on heart and fluid dynamics: a 6-month follow up study

      ea0014p35
    • Peculiarities of heart rate control in patients with non-insulin dependent diabetes mellitus and hypertension

      ea0014p36
    • One injection of Detemir insulin administered before the lunch improves the metabolic control in type 1 diabetic patients

      ea0014p37
    • Oral antibodies to insulin receptor are found effective in the treatment of streptozotocin-induced diabetes in rats

      ea0014p38
    • 1 year endurance training at the level of the ventilatory threshold in type-2 diabetics reduces by 50% healh costs: a controlled randomized trial

      ea0014p39
    • PED levels are increased in peripheral blood leucocytes from euglycaemic subjects at-risk of type 2 diabetes

      ea0014p40
    • Effectiveness of α-lipoic acid in prevention of peripheral diabetic neuropathy

      ea0014p41
    • Adhesion molecules s-VCAM-1 and s-ICAM-1 in members of families with familial combined hyperlipidemia

      ea0014p42
    • Body fat distribution, lipid and adipokine levels in South African type 2 diabetic patients of African and Indian origin

      ea0014p43
    • Low dose cyclosporin and methotrexate administration induces remission of Type 1 diabetes mellitus

      ea0014p44
    • Progression of diabetic retinopathy in pregestational diabetes mellitus

      ea0014p45
    • Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acorbose in type 2 diabetes

      ea0014p46
    • Competition between catecholamines and glucose for binding sites on proteins of erythrocytes

      ea0014p47
    • Body composition, emotional state and quality of life in patients with diabetes mellitus type 2

      ea0014p48
    • Deleterious effects of beta-blockers on arterial stiffness and central pulse pressure in menopausal women: baseline findings from the Cashmere trial

      ea0014p49
    • Prevalence of GADA and IAA in elderly patients with type 2 diabetes

      ea0014p50
    • Comparison of plasma homocysteine concentrations (HYC) in patients with acute coronary syndrome (ACS) and newly or previously diagnosed type 2 diabetes

      ea0014p51
    • The association between carotid artery intima-media thickness and cardiovascular mortality and morbidity in Type 2 diabetes: a retrospective study

      ea0014p52
    • Comparison of the effects of gliclazide and glibenclamide on insulin resistance and metabolic parameters

      ea0014p53
    • 24-hour ambulatory blood pressure and aortic dimensions in women with Turner syndrome

      ea0014p54
    • Plasma marker of lipid peroxidation and type 2 diabetes in subject with coronary artery disease in Iranian subjects

      ea0014p55
    • Effect of testosterone replacement therapy on adipocytokines in hypogonadal men with Type 2 diabetes

      ea0014p57
    • Effect of testosterone replacement therapy on adipocytokines in hypogonadal men with Type 2 diabetes

      ea0014p57 (1)
    • A role of the liver in the infringements of lipid metabolism of patients with diabetes mellitus type 2 and metabolic syndrome

      ea0014p58
    • Radionuclide study of hepatobiliary system function in patients with type 2 diabetes and metabolic syndrome

      ea0014p59
    • Omega-3 polyunsaturated fatty acids in the treatment of cardiovascular autonomic neuropathy in Type 2 diabetes mellitus patients

      ea0014p60
    • Nicotinamide and alpha-lipoic acid in the treatment of cardiovascular autonomic neuropathy in Type 2 diabetic patients

      ea0014p61
    • Plasma measures of oxidative stress and antioxidant status in type 2 diabetes mellitus

      ea0014p62
    • Does screening of primary hyperaldosteronism only lead to diagnosis of more adrenal hyperplasia?

      ea0014p63
    • Liquorice in moderate doses decreases serum levels of vitamin B12 but does not affect the serum lipid levels

      ea0014p64
    • Decreased insulin sensitivity in young lean hypertensive men is not associated with increased visceral fat and changes in plasma adipocytokines

      ea0014p65
    • Comparison of twice daily NPH insulin versus once daily glargine insulin in the frequency of nocturnal hypoglycemia in Type2 diabetic patients with congestive heart failure

      ea0014p66
    • Intravenous constant ghrelin infusion in healthy young men: sustained cardiovascular effects of supraphysiological ghrelin levels

      ea0014p67
    • Circulating retinol binding protein 4 and protein C inhibitor are not related to insulin resistance

      ea0014p68
    • KCNJ11 and ABCC8 promotor variants in congenital hyperinsulinism

      ea0014p69
    • Effect of L- carnitine supplementation on glycemic profile in patients with type 2 diabetes mellitus

      ea0014p70
    • Raised serum, adipocyte and adipose tissue retinol binding protein 4 (RBP4) in women with polycystic ovary syndrome

      ea0014p71
    • Polymorphisms of von Willebrand factor gene promoter modulate the corticosteroid-mediated increase of VWF levels in Cushing’s syndrome.

      ea0014p72
    • Circulating pro- and anti-inflammatory cytokines in women with gestational diabetes

      ea0014p73
    • Metabolic improvement in diabetic patients with glucose continuous monitoritation in real time

      ea0014p75
    • The role of stress related aldosterone secretion in essential hypertension

      ea0014p76
    • Dialysis therapy and its complications

      ea0014p77
    • The effect of interferon treatment on glucose metabolism in patients with chronic hepatitis

      ea0014p78
    • Unacylated ghrelin (UAG) enhances the early insulin response to meal, improves glucose metabolism and decreases free fatty acids levels in healthy volunteers

      ea0014p79
    • Weight-related concentrations of steroid hormones in patients of both sexes with preserved gonadal function suffering from coronary artery disease

      ea0014p80
    • Diabetic patient’s evaluation of continuous glucose monitoring sensors versus capillary glucose measurements

      ea0014p81
    • Dehydroepiandrosterone therapy in men with verified coronary heart disease: the effects on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA)

      ea0014p82
    • Insulin resistance and insulin secretion in non-diabetic acromegalic patients

      ea0014p83
    • Response to metformin treatment in adolescent siblings with familial partial lipodystrophy of the dunnigan variety (FPLD) due to the R482W LMNA gene mutation

      ea0014p84
    • Insulin sensitivity and lipid levels in pateints with primary hyperparathyroidism

      ea0014p85
    • The effect of surgical treatment on insulin sensitivity in pateints with primary hyperparathyroidism

      ea0014p86
    • Insulin-sensitivity and glycaemic control improve on rosuvastatin (RSV) treatment in hypertriglyceridaemic type-2 diabetes (T2DM)

      ea0014p87
    • Gestational diabetes mellitus and adiponectin levels

      ea0014p88
    • Lipoprotein Lp(a) in patients with systemic lupus erythematosus. Relationship with disease activity and anticardiolipin antibodies

      ea0014p89
    • Lipoprotein Lp(a) in patients with rheumatoid arthritis and its relationship with disease activity

      ea0014p90
    • Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients, who display fat redistribution

      ea0014p91
    • Concentration of vasopressin and of N- terminated naturetic propeptyde type B – potent predictors of survival of patients after cardiac arrest

      ea0014p92
    • Changes in plasma adiponectin during the treatment of diabetic ketoacidosis

      ea0014p93
    • Power spectral analysis (PSA) of heart rate variability (HRV) in the detection of cardiac autonomic neuropathy (CAN) in subjects with diabetes mellitus

      ea0014p94
    • Glicoregulation in obese diabetics treated with glargin insulin in combination with metformin and with glargin in combination with glimepirid

      ea0014p95
    • High-sensitivity C-reactive protein in diabetes mellitus type II according to micral test findings

      ea0014p96
    • Localization of an ectopic adrenocorticotropin-secreting tumour using ¹⁸F- Dopa PET/CT

      ea0014p97
    • Adrenocortical carcinosarcoma: first european case report

      ea0014p98
    • The genetic association of medullary thyroid carcinoma with Hirschsprung’s disease

      ea0014p99
    • Inhibition of C_17,20-lyase activity by new 17β-exo-heterocyclic androsterone derivatives

      ea0014p100
    • Cigarette smoking increases high calcitonin levels

      ea0014p101
    • Cortisol excess, inflammatory markers and echocardiographic alterations in adrenal incidentalomas

      ea0014p102
    • Prognostic value of anti-thyroperoxidase antibodies in high malignancy degree breast cancer

      ea0014p103
    • Bone density in patients with non-functioning pituitary adenomas (NFA)

      ea0014p104
    • Echo-enhanced ultrasound has a higher sensitivity than high-resolution CT in the detection of hepatic metastasis of adrenocortical carcinoma

      ea0014p105
    • Characteristics of metabolic syndrome in patients with adrenal incidentaloma

      ea0014p106
    • The role of radio-guided surgery (RGS) with the use of ^99mTc-EDDA/HYNIC-octreotate in detection of unknown primary and secondary sites of neuroendocrine tumours of the gastrointestinal tract (GEP-NET) and improving the final outcome of patients

      ea0014p107
    • Ascl1 is abundantly expressed in endocrine pancreatic tumors

      ea0014p108
    • Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?

      ea0014p109
    • Thyroid cancer and pregnancy: clinical outcome and time of diagnosis in a series of 94 women

      ea0014p110
    • RET genotypes comprising specific haplotypes of polymorphic variants are associated with sporadic medullary thyroid cancer

      ea0014p111
    • Isolation of the Side population (SP) from murine adrenal glands renders cells with adrenocortical stem cell properties

      ea0014p112
    • Selective intra-arterial calcium stimulation with hepatic venous sampling in investigation of hyperinsulinemic hypoglycemia

      ea0014p113
    • Somatostatin and dopamine receptor regulation and effects of a new somatostatin/dopamine chimeric compound on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

      ea0014p114
    • Somatostatin receptor regulation and effects of somatostatin and somatostatin analogues on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

      ea0014p115
    • Conjugated and unconjugated serum steroid hormone concentrations in relation to tumour receptor status in postmenopausal breast cancer patients

      ea0014p116
    • A novel activating germline mutation in the RET gene (Y606C) in a patient with medullary thyroid carcinoma

      ea0014p117
    • Novel germline VHL mutations associated to uncommon clinical presentations

      ea0014p118
    • The expression of alternatively spliced forms of type 1 deiodinase is changed in clear cell renal cell carcinoma

      ea0014p119
    • Ret expression reduces estrogen-induced lactotrope hyperplasia

      ea0014p120
    • Analysis of BRAF point mutation in papillary thyroid carcinoma

      ea0014p121
    • Effect of surgery on carotid vascular remodeling in patients with pheochromocytoma

      ea0014p122
    • A case report of ectopic Cushing’s disease presented with trombocytopenia

      ea0014p123
    • Influence of Lanreotide Autogel on insulin sensitivity among patients with acromegaly

      ea0014p124
    • A newly detected mutation of the RET proto-oncogene in exon 8 as a cause of multiple endocrine neoplasia Type 2A

      ea0014p125
    • Clinical and biochemical effects of adjuvant mitotane treatment in patients with adrenocortical cancer (ACC)

      ea0014p126
    • Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake

      ea0014p127
    • Expression of the neuropeptide cortistatin in haematological malignancies

      ea0014p128
    • A loss-of-function polymorphic mutation in the P2X7 receptor gene in patients with papillary thyroid cancer

      ea0014p129
    • Enhanced expression of functional P2X₇ receptor in human papillary thyroid cancer

      ea0014p130
    • Results 90Y-DOTATATE therapy in patients with neuroendocrine tumours (NETs) - own experience

      ea0014p131
    • Results of treatment of patients with pituitary somatotroph adenomas

      ea0014p132
    • Adrenal incidentaloma, an oncological or endocrinological enigma? Clinical analysis of 1300 cases observed at a single endocrinological centre

      ea0014p133
    • Frequency and type of adrenal tumors in our patients

      ea0014p134
    • Papillary thyroid cancer – the possible role of death ligands in tumor immunology

      ea0014p135
    • Leptin and adiponectin interact in regulating prostate cancer cell growth

      ea0014p136
    • A novel role for Visfatin/Pre-B cell colony-enhancing factor 1 (PBEF)/Nicotinamide phosphoribosyltransferase (NMPRTase) in prostate carcinogenesis

      ea0014p137
    • Initial presentation of patients with acromegaly - analysis of the German acromegaly register

      ea0014p138
    • Survivin – a promising target for immunotherapy in patients with adrenocortical carcinoma

      ea0014p139
    • Thyroid cancer: with an unexpected location – in the pancreas and in an unexpected combination with Boeck’s sarcoidosis

      ea0014p140
    • Thyroglobulin-antibodies in the “normal” range may decrease the diagnostic accuracy of thyroglobulin in the care of patients with differentiated thyroid cancer

      ea0014p141
    • Dopamine receptor expression and dopamine agonist effectiveness in post-surgical persistent medullary thyroid cancer

      ea0014p142
    • Somatostatin analogues and the PI3K-AKT-MTOR-P70S6K pathway: how do they control the proliferation of neuroendocrine tumours?

      ea0014p143
    • Angiotensin 4–8 and angiotensin 5–8 inhibit cell proliferation in GH3 rat pituitary lactosomatotroph tumor cell culture

      ea0014p144
    • Epidermal growth factor receptor (EGFR) as a potential new target in the treatment of patients with adrenocortical carcinoma – results of pre-clinical studies

      ea0014p145
    • Time necessary to achieve the maximum effect of goserelin, LH-RH agonist, in therapy of hormone dependent breast cancer

      ea0014p146
    • Acromegaly due to a lung carcinoid: a case report

      ea0014p147
    • Intra- and supra-sellar immature teratoma mimicking pediatric craniopharyngioma

      ea0014p148
    • Pituitary microprocess

      ea0014p149
    • Adrenal incidentalomas and insulin sensitivity – are there any differences between adenomas and hyperplasia?

      ea0014p150
    • Frequency of occurence of MEN1 syndrome in patients admitted with primary hyperthyroidism

      ea0014p151
    • Evaluation of the efficacy of sandostatin LAR in the treatment of acromegaly

      ea0014p152
    • The beta-HLH transcription factor neurogenin-2 is preferentially expressed by secreting pituitary adenomas

      ea0014p153
    • TGFß1 signalling in human insulinomas compared with human islets.

      ea0014p154
    • The effect of SOM230 on cell proliferation and cortisol secretion in the human adrenal carcinoma cell line H295R

      ea0014p155
    • MEN2B – Two simultaneous cases of a rare syndrome

      ea0014p156
    • Prevalence of autonomous cortisol and aldosterone secretion in patients with a single benign cortical adrenal adenoma after modification of the diagnostic tests

      ea0014p157
    • Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors

      ea0014p158
    • Bilateral adrenal incidentalomas: exploration of aberrant responses and comparison with unilateral lesions

      ea0014p159
    • Inhibitory effect of rosiglitazone – PPARgamma receptor ligand on growth of human adrenocortical tumor cells in vitro

      ea0014p160
    • The modern pre- and intraoperative diagnostic algorithm of pancreatic NET with the use of 99mTc-EDDA/HYNIC-octreate scintigraphy – the impact of SRS on patients’ management

      ea0014p161
    • Segregation of P25L and S80I mutations of the vhl gene in an extended Hungarian family with von Hippel-Lindau syndrome

      ea0014p162
    • High prevalence of novel mutations of the MEN1 gene in Hungarian patients with multiple endocrine neoplasia type 1

      ea0014p163
    • Analysis of germline mutations in patients with pheochromocytomas and paragangliomas

      ea0014p164
    • RET exon 13 germline polymorphism in patients with pheochromocytomas and paragangliomas

      ea0014p165
    • Cabergoline suppression test in distinguishing the variability of response to dopamine agonists in prolactinomas

      ea0014p166
    • Predictive value of pituitary histology on clinical outcome in acromegaly: a retrospective cohort study

      ea0014p167
    • Somatostatin receptor immunohistochemistry in neuroendocrine tumors: a proposal of scoring system for clinical characterization and therapy selection

      ea0014p168
    • Prevalence of primary aldosteronism among hypertensive patients (preliminary results)

      ea0014p169
    • Leptin modulates the growth of murine Colon 38 cancer and interferes with the cytotoxic effect of fluorouracil in vitro

      ea0014p170
    • Muscle mitochondrial function is impaired in patients with prior acromegaly

      ea0014p171
    • Diagnosis and treatment of the ACTH-secreting neuroendocrine pancreatic tumors

      ea0014p172
    • Novel mutations in genes encoding succinate dehydrogenase complex subunits B (SDHB) and von Hippel-Lindau protein (VHL) in patients with nonsyndromic pheochromocytoma

      ea0014p173
    • Evaluation of plasma and urinary metanephrines as well as serum chromogranin A for the diagnosis of pheochromocytoma

      ea0014p174
    • ¹¹C-5-hydroxytryptophan PET scan in diagnosis of ectopic Cushing’s syndrome from typical lung carcinoid: a case report

      ea0014p175
    • Mutational analysis in patients with nonsyndromic MEN1

      ea0014p176
    • Screening for mutations in exon 10, 11, 13 and 14 of the RET protooncogene associated with inherited medullary thiroid carcinoma (MTC) in Serbian population

      ea0014p177
    • The use of ¹⁸F-FDG PET/CT with or without rhTSH stimulation during follow-up of patients with differentiated thyroid carcinoma

      ea0014p178
    • Lower catch-up growth under rGH therapy at pre-pubertal pituitary dwarves diagnosed at an older age

      ea0014p180
    • The growth hormone – insulin-like growth factor-I axis in adult thalassemic patients

      ea0014p181
    • The role of BMP-3B in the establishment of zona glomerulosa in the adrenal gland

      ea0014p182
    • Selenium supply modulates growth spurt of selenoprotein P knockout mice

      ea0014p183
    • Factors affecting height velocity (HV) during GnRH analog therapy in girls with central precocious puberty (CPP)

      ea0014p184
    • Auxological and IGF system parameters in African in comparison with western countries normal children

      ea0014p185
    • X-linked neuronal T₃ transport defect: Allan Herndon Dudley syndrome

      ea0014p186
    • Cephalometric analysis and dental maturation in patients with Turner’s syndrome (TS)

      ea0014p187
    • Craniofacial development and dental maturation in growth hormone(GH)-deficient patients

      ea0014p188
    • Developing brain as an endocrine gland secreting GnRH and dopamine to general circulation

      ea0014p189
    • Closure by iptakalim, a cardiovascular K(ATP) channel opener, of rat islet beta-cell K(ATP) channels and its molecular basis

      ea0014p190
    • Plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes

      ea0014p191
    • Pioglitazone modifies the effects of growth hormone on lipolysis and insulin sensitivity

      ea0014p192
    • The metabolic syndrome and associated sexual dysfunction: psychobiological correlates

      ea0014p193
    • A comparison of NCEP-ATP-III and IDF metabolic syndrome definitions with relation to metabolic syndrome associated sexual dysfunction

      ea0014p194
    • Effect of supervised structured exercise program for 16 weeks on metabolic, pulmonary and cardiovascular parameters in obese adolescents

      ea0014p195
    • Continuous administration of dihydrotestosterone or letrozole to immature female rats results in polycystic ovary syndrome characteristics at adult age

      ea0014p196
    • Neonatal sex steroid exposure of female rats results in insulin resistance and enlarged mesenteric adipocytes

      ea0014p197
    • Evaluation of visceral protein malnutrition in morbid obese patients operated on laparoscopic gastric bypass

      ea0014p198
    • Overconsumption of salty and sweet foods increases blood pressure in children

      ea0014p199
    • Expression of PKA regulatory subunits inversely correlates with BMI and insulin resistance parameters in human adipocytes from lean and obese subjects

      ea0014p200
    • Insulin resistance and fasting leptin’s relationship in subjects with metabolic syndrome

      ea0014p201
    • Epicardial adipose tissue, hepatic steatosis and obesity

      ea0014p202
    • Decreased 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys

      ea0014p203
    • Clinical presentation of nonclassic congenital adrenal hyperplasia &br;(NC-CAH): from suspicion to diagnosis

      ea0014p204
    • Daily and nightly urinary free cortisol ratio as a marker of the hypothalamic-pituitary-adrenal (HPA) axis activity in abdominal obesity

      ea0014p205
    • Interaction of hypothalamic receptors involved in weight regulation

      ea0014p206
    • Association of estrogen receptor-alpha gene polymorphisms with cerebrovascular disease in patients with metabolic syndrome

      ea0014p207
    • Bone mineral density and body composition in pubescent obese children endangered by metabolic syndrome

      ea0014p208
    • Influence of gaining weight on metabolic syndrome in the menopause

      ea0014p209
    • Effects of physiological bell-shaped elevations of free fatty acids on glucose metabolism and insulin sensitivity in humans

      ea0014p210
    • The metabolic changes induced by glucocorticoids: involvement of AMP-activated protein kinase

      ea0014p211
    • Net endogenous acid production and circulating leptin are associated with potentially bioactive free glucocorticoids in healthy lean women

      ea0014p212
    • Serum gamma-glutamiltransferase increases in type 2 diabetes mellitus but it is not related with the body mass index

      ea0014p213
    • Effects of pharmacological stimulation or blockade of cannabinoid receptor type 1 (CB1) on gene expression in mouse cultured adipocyte cells

      ea0014p214
    • Absence of TSH-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing rhTSH testing

      ea0014p215
    • Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome

      ea0014p216
    • Relationship between serum adiponectin and oxidative and non-oxidative glucose metabolism in apparently healthy humans

      ea0014p217
    • Relationships between serum adiponectin, interleukin 10 and interleukin 18 concentrations and muscle lipid fractions in healthy humans

      ea0014p218
    • Prevalence of metabolic syndrome in old men and its relation to ghrelin

      ea0014p219
    • Antipsychotic drugs and associated metabolic disorders

      ea0014p220
    • Associations between thyroid function parameters and adipokines in euthyroid individuals

      ea0014p221
    • Human adipose tissue derived DPP-IV regulates lipolysis through NPY in cultured abdominal subcutaneous adipocytes

      ea0014p222
    • The role of nitric oxide in pathogenesis of development of arterial hypertension during obesity

      ea0014p223
    • Effects of PGC-1α on endothelial function and apoptosis

      ea0014p224
    • Changes in serum glucose metabolism and growth hormone, cortisol, prolactin, ghrelin, leptin concentrations in normal weight patients with schizophrenia before treatment with atypical antipsychotics

      ea0014p225
    • Frequency of hypogonadism in males with type 2 diabetes and its relation with erectile dysfunction and obesity

      ea0014p226
    • Acute phase reactants and soluble cell adhesion molecules are associated to plasma leptin levels in obese nondiabetic children

      ea0014p227
    • Relationship between homocysteine level and low-grade systemic inflammation in obese children with metabolic syndrome

      ea0014p228
    • Oxidative stress and antioxidant defense is associated with adiposity in men among the urban population of south Iran

      ea0014p229
    • Ghrelin basal levels in metabolic syndrome

      ea0014p230
    • Pioglitazone treatment significantly decreases 5-alpha reductase activity and improves metabolic risk factors in PCOS

      ea0014p231
    • Plasma adiponectin and leptin levels in menopausal metabolic syndrome

      ea0014p232
    • Serum interleukin 6 and soluble form of interleukin 6 receptor concentrations in obese subjects with impaired glucose tolerance

      ea0014p233
    • Association of sex hormone-binding globulin (shbg) levels with measures of adiposity and metabolic profile in apparently healthy individuals

      ea0014p234
    • Comparative analysis of adiponectin, leptin and C-peptide levels in obese non-diabetic, type 1 diabetic and lean non-diabetic children

      ea0014p235
    • Effects of pioglitazone and metformin on body weight and the insulin resistance parameters in young patients with obesity

      ea0014p236
    • Plasma visfatin levels during oral glucose tolerance test in obese women

      ea0014p237
    • The association of high sensitivity C-reactive protein levels with body fat mass and body fat distribution

      ea0014p238
    • Innervation of white and brown adipose tissue: dual viral transneuronal tracing study

      ea0014p239
    • Identification of orexin receptors in brown adipocytes: functional effects of orexin-B

      ea0014p240
    • Waist circumference and BMI as predictors of arterial hypertension in childhood and adolescence in Latvia

      ea0014p241
    • Uric acid is an important predictor of metabolic disturbances in obese women

      ea0014p242
    • Fasting and postprandial plasma obestatin levels are reduced in obesity

      ea0014p243
    • Insulin resistance and insulin secretion in morbidly obese patients before and six months after bariatric surgery

      ea0014p244
    • Growth hormone Reduces Inflammation in Postmenopausal Women with Abdominal Obesity: a 12-month randomized placebo-controlled trial

      ea0014p245
    • Hyperactivity of the hypothalamic-pituitary-axis and adrenal hyperandrogenism in polycystic ovary syndrome: a consequence of 5 β-reductase hyperfunction

      ea0014p246
    • An examination of the prevalence of IDF and ATPIII defined metabolic syndrome: towards population based screening

      ea0014p247
    • Neuroendocrine and genetic aspects of metabolic disturbances in women with simple obesity, polycystic ovary syndrome (PCOS) and eating disorders

      ea0014p248
    • The effect of body composition and iron status on insulin resistance in hemodialysis patients

      ea0014p249
    • Relationship between obesity, insulin resistance and adipokines in morbidly obese women

      ea0014p250
    • Obesity in pre-school children –new epidemic problem?

      ea0014p251
    • Somatostatin receptor subtype 2 inhibits glucagon secretion and regulates glucose homeostasis

      ea0014p252
    • The role of combined treatment of arterial hypertension in patients with obesity

      ea0014p253
    • A registry of GDM in portugal

      ea0014p254
    • The effects of glucocorticoids on the expression of gluconeogenic and lipogenic enzymes in a rodent model of Cushing’s syndrome

      ea0014p255
    • HRT in treatment of dislipidemia in women with hypogonadotropic hypogonadism

      ea0014p256
    • Rare polimorphism in the intron of human Agouti- related protein gene is associated with obesity

      ea0014p257
    • The relationship between plasma androgens (testosterone and dehydroepiandrosterone sulfate), insulin resistance and visceral obesity in elderly men

      ea0014p258
    • Prevalence of metabolic syndrome in a cohort of young Mediterranean women with polycystic ovary syndrome and association with clinical and biochemical parameters

      ea0014p259
    • Obesity: diffusion weighted imaging features of brain

      ea0014p260
    • Hepatic and brain metabolism in young adults with glycogen storage disease type 1

      ea0014p261
    • Body composition and GH status in morbidly obese females before and after laparoscopic silicone adjustable-gastric banding

      ea0014p262
    • The importance of (TAAAA)n polymorphism of SHBG gene in the metabolic syndrome

      ea0014p263
    • Exophthalmos and its relation to adipokines in obese men

      ea0014p264
    • Influence of orlistat on adiponectin levels in obese women

      ea0014p265
    • Effect of omega-3 fatty acids on plasma adiponectin levels in Metabolic syndrome subjects

      ea0014p266
    • The polymorphism of PPAR and susceptibility to atherosclerosis in children with low birth weight (below 2500 g)

      ea0014p267
    • Visfatin, adiponectin, leptin and insulin sensitivity in severe obese women with normal and impaired glucose tolerance

      ea0014p268
    • Characterization of the rat homologue of the human neuroendocrine marker secretagogin – new functional implications by in vitro studies

      ea0014p269
    • Tilapia GnRH receptors: signal transduction and internalization rate

      ea0014p270
    • The relationship between carotid intima-media thickness metabolic and anthropometric parameters in healthy subjects

      ea0014p271
    • CRF and the Urocortins activate NFAT and induce catecholamine production in PC12 cells

      ea0014p272
    • Gs-dependent receptor endocytosis of melanocortin-4 receptors

      ea0014p273
    • The endocrine disruptor DDT appears to be an uncompetitive inverse agonist for activating TSHr mutants, FSH receptor and LH receptor

      ea0014p274
    • Effect of vitamin D replacement on endothelial function and oxidative stress in vitamin D deficient subjects

      ea0014p275
    • Transthyretin is up-regulated by androgens in mice liver and choroid plexus

      ea0014p276
    • Adrenal incidentalomas: aberrant expression of hormone receptors (preliminary results)

      ea0014p277
    • SMP30 is expressed in rat mammary gland and down-regulated by estradiol

      ea0014p278
    • Family mutation of PRKRA1A associated with Cushing syndrome from pigmented micronodular adrenal dysplasia

      ea0014p279
    • Non-genomic glucocorticoid effects on insulin secretion

      ea0014p280
    • The androgen receptor in the rat choroid plexus

      ea0014p281
    • Correlation of BclI, N363S and the ER22/23EK polymorphisms of the glucocorticoid receptor gene and bone mineral density in patients with endogenous and exogenous hypercortisolism

      ea0014p282
    • In vitro effects of 17 βE₂ and raloxifene on desmoid tumour derived cells

      ea0014p283
    • ESR2 genotypes are associated with a reduced relative risk for sporadic colorectal cancer

      ea0014p284
    • Frequency of three major glucocorticoid receptor gene polymorphisms in patients with adrenal incidentalomas

      ea0014p285
    • An analysis on delays in diagnosis of papillary thyroid cancer

      ea0014p286
    • Post-treatment effects of maternal hypothyroidism and thyroxin therapy on the subiculum neuronal density of the newborn rats

      ea0014p287
    • Abstract unavailable

      ea0014p288
    • The effects of subclinical hypothyroidism and replacement therapy on paraoxonase-1 (PON-1) and common carotis intima media thickness

      ea0014p289
    • Elevated plasma FABP4 (aP2) levels in hypothyroidism: potential implication for accelerated atherosclerosis

      ea0014p290
    • Markers of REDOX system at autoimmune diseases of thyroid gland

      ea0014p291
    • Selenium and its relation to thyroid antibodies, volume and ultrasound texture

      ea0014p292
    • Which prognosis criteria for thyroid anaplastic carcinoma?

      ea0014p293
    • Clinical-epidemiological characteristics of thyroid cancer (TC) in the Crimea

      ea0014p294
    • Fine needle aspiration biopsy of the thyroid. Cytohistologic correlation: experience in a central military hospital

      ea0014p295
    • Thyroid nodules in the elderly: role of ultrasound (US) and ultrasound-guided fine-needle aspiration biopsy (US-FNAB)

      ea0014p296
    • Clinical and pathological characteristics of thyroid anaplastic carcinoma: a regional survey in Auvergne

      ea0014p297
    • Abstract unavailable

      ea0014p298
    • Serum n-terminal pro-b-type natriuretic peptide (NT-proBNP) levels in patients with hyper- and hypothyroidism. Hyperthyroidism may affect NT-proBNP levels as independent of cardiac dysfunction

      ea0014p299
    • Soluble intercellular adhesion molecule-1(sICAM-1) levels and different schemes of Graves’ ophthalmopathy (GO) treatment

      ea0014p300
    • The influence of smoking upon the incidence of Graves’ disease and severity of Graves’ ophthalmopathy

      ea0014p301
    • Fewer and fewer thyroidectomies in the treatment of Graves’ disease

      ea0014p302
    • The prevalence of thyroid cancer in Albania

      ea0014p303
    • The prevalence of anti-C1q antibodies is increased in autoimmune thyroid disorders

      ea0014p304
    • The analgesic efficacy of lidocaine/prilocaine (EMLA) cream during the fine-needle aspiration biopsy of thyroid nodules

      ea0014p305
    • Radioactive iodine in the treatment of type 2 amiodarone-induced thyrotoxicosis

      ea0014p306
    • The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism

      ea0014p307
    • The role of parathyroid hormone monitoring after total thyroidectomy in predicting post-thyroidectomy related hypocalcaemia

      ea0014p308
    • Abstract unavailable

      ea0014p309
    • Intraorbital tissues effects of rituximab (RTX) treatment in patients with thyroid-associated ophthalmopathy (TAO)

      ea0014p310
    • Thyroid and gastric autoimmune diseases

      ea0014p311
    • VEGF, FGF and HGF in differentiated thyroid cancer

      ea0014p312
    • Fas and FasL expression on peripheral lymphocytes in patients with autoimmune thyroid disease

      ea0014p313
    • A novel pro-migratory action of TGFb in papillary carcinoma

      ea0014p314
    • Significance of accurate serum thyroglobulin cut-off values in the postoperative follow-up of differentiated thyroid carcinoma

      ea0014p315
    • Thyroid ultrasonography and ultrasonography-guided fine-needle aspiration biopsy of thyroid nodules in correlation with pathological findings

      ea0014p316
    • Different prevalence of type 1 and type 2 amiodarone-induced thyrotoxicosis over a 30-year period

      ea0014p317
    • Carbamazepine and risk of hypothyroidism: a prospective study

      ea0014p318
    • Epidemiology of thyroid cancer in the north eastern region of Poland

      ea0014p319
    • The Na⁺/I⁻ symporter (NIS) transports two of its substrates, I⁻ and ClO₄⁻, with different stoichiometries

      ea0014p320
    • Estimation of influence radioiodine treatment on course of Graves’ ophthalmopathy

      ea0014p321
    • Influence of a subclinical thyrotoxicosis on heart in various age-grades

      ea0014p322
    • Thyroid abnormalities during treatment with PEGIFNα-2a and PEGIFNα-2b in patients affected by HCV-related chronic disease: &br;a prospective randomized study

      ea0014p323
    • The effect of L-thyroxin theraphy on left ventricular diastolic dysfunction in patients with subclinical hypothyroidism

      ea0014p324
    • Risk factors for thyrotoxic cardiomyopathy

      ea0014p325
    • Partial withdrawal of levothyroxine to stimulate serum thyroglobulin (TG) in the follow-up of differentiated thyroid carcinoma (DTC)

      ea0014p326
    • Selected markers of endothelial dysfunction in patients with subclinical and overt hyperthyroidism

      ea0014p327
    • The changes in the incidence of nodular goitre, thyroid cancer and urine excretion of iodine in the inhabitants of north eastern Poland in 1997 and 2005

      ea0014p328
    • The role of deiodinases in thyronamine biosynthesis

      ea0014p329
    • Thyroid disease prevalance in Cushing’s disease

      ea0014p330
    • From sampling to analytics: experience and diagnostic consequences with some thyroid markers

      ea0014p331
    • G_q/11-dependent signaling of the tyhrotropin receptor regulates metallothionein 1 expression in human thyroid carcinoma cells

      ea0014p332
    • Association of cytokine gene polymorphism with Graves’ disease in Turkish population

      ea0014p333
    • Hashimoto’s encephalitis: role of diagnostic SPECT

      ea0014p334
    • Usefulness of Ki-67, PCNA, c-erbB-2 and CK 19 in the diagnosis of some thyroid follicular tumors

      ea0014p335
    • Soluble CTLA-4 is increased in Graves’ disease and not related to thyroid status or ophthalmopathy severity

      ea0014p336
    • The relationship of epicardial fat thickness with carotid intima media thickness and endothelial function in subclinical and overt hypothyroidism

      ea0014p337
    • Prevalence of thyroid antibodies in gestational diabetes mellitus

      ea0014p338
    • Thyroid investigation profile in patients with Hashimoto’s thyroiditis associated with other autoimmune disorders

      ea0014p339
    • Ultrasound patterns in patients with autoimmune thyroiditis

      ea0014p340
    • Iodine intake in Portugal: preliminary results in pregnant women

      ea0014p341
    • “False negative” results of Tg in patients with DTC (differentiated thyroid carcinoma)

      ea0014p342
    • The incidence of Hashimoto’s thyroiditis in the differentiated thyroid carcinoma

      ea0014p343
    • Thyroid cancer radioidine therapy using recombinant human TSH

      ea0014p344
    • Characterization of facilitative glucose transporters (GLUT) in human thyroid carcinoma cell lines

      ea0014p345
    • Genotype/phenotype relation for toxic thyroid nodules with or without TSH receptor mutations

      ea0014p346
    • High prevalence of ER22/23EK polymorphism of the glucocorticoid receptor gene in patients with Graves’ orbitopathy

      ea0014p347
    • Removal of tick box for TFT in pathology request forms reduces TFT performed during acute medical admission

      ea0014p348
    • Thyroid hormones in serum and cerebrospinal fluid in patients with brain tumor and acute stroke

      ea0014p349
    • The influence of universal salt-iodization on the iodine status of County Mures, detected through TSH determinations in newborns between 2001–2006

      ea0014p350
    • The evolution of hypothyroidism in pregnant women in County Mures between 2001–2006

      ea0014p351
    • The use of perchlorates in the treatment of some special forms of hyperthyroidism (report of two cases)

      ea0014p352
    • Iodine deficiency detected through urinary iodine excretion in school-children living in goiter prevalent regions of County Mures (2005–2006)

      ea0014p353
    • Endothelial function and hemostasis factors in hypothyroidism and subclinical hyperthyroidism

      ea0014p354
    • The relevance of thyroid echography in diagnostic of subclinical autoimmune thyroiditis during pregnancy and postpartum

      ea0014p355
    • Outcomes of a fixed dose of 370 MBq of radioiodine in hyperthyroidism

      ea0014p356
    • The lymphocyte interactions in thyroid tissue in graves’ disease

      ea0014p357
    • Water purification technology reduces iodine content of drinking water and contributes to iodine deficiency

      ea0014p358
    • The ultrastructural changes of thyroid tissue in recipient of bone marrow graft with Graves’ disease

      ea0014p359
    • Do patients and clinicians agree about which aspects of quality of life are relevant when evaluating the impact of thyroid diseases?

      ea0014p360
    • ret/PTC oncogene expression in papillary thyroid carcinoma

      ea0014p361
    • Prognostic value of polymorphisms and somatic RET proto-oncogene mutations in sporadic medullary thyroid carcinoma (MTC)

      ea0014p362
    • Partial redifferentiation of thyroid carcinoma cell lines treated with decitabine and retinoic acid

      ea0014p363
    • Comparison between serum calcitonin (CT) levels following Pentagastrin (Pg) and Calcium (CA) stimulus

      ea0014p364
    • Usefulness of calcitonin (CT) measurement in wash-out fluid from fine needle aspiration biopsy in thyroid nodules of patients with dectectable serum CT

      ea0014p365
    • Prognostic significance of BRAF mutation in patients affected by papillary thyroid carcinoma with a follow up of 20 years

      ea0014p366
    • Expression of folate receptor is down-regulated in somatotropinomas

      ea0014p367
    • Initiating mutations of BRAF gene in papillary thyroid carcinoma and their relation to gene expression profile

      ea0014p368
    • CRABP2 expression is up-regulated in parathyroid adenomas in correlation with HRPT2 down-regulation

      ea0014p369
    • Hypothyroid Graves’ ophthalmopathy: a case report

      ea0014p370
    • Increased risk of cardiovascular events in subclinical hyperthyroidism

      ea0014p371
    • Predictive factors for thyroid function abnormalities in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

      ea0014p372
    • Aetiology and therapeutic guideines in thyrid dysfunction at the patients with chronic hepatitis C treated with pegylated interferon and ribavirin

      ea0014p373
    • Thyroid function in pregnancy

      ea0014p374
    • Painful Hashimoto’s thyroiditis – 2 cases report

      ea0014p375
    • Increase of L-thyroxine requirement during pregnancy

      ea0014p376
    • Safety of pharmacological treatment of thyroid diseases &br;during pregnancy

      ea0014p377
    • Fine-needle aspiration biopsy – possibilities and limitations

      ea0014p378
    • Association of p53 codon 72 polymorphism with thyroid cancer

      ea0014p379
    • Adiponectin in patients with Graves’ ophthalmopathy (GO)

      ea0014p380
    • Resistin levels in hypothyroid patients before and after treatment &br;with thyroxin

      ea0014p381
    • Increased need for oral thyroxine in total thyroidectomized patients: a prospective analysis

      ea0014p382
    • Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients

      ea0014p383
    • The effect of nodule size on diagnostic efficacy in fine needle aspiration biopsy of thyroid nodules

      ea0014p384
    • The effect of thyroxine suppression therapy on the diagnostic efficacy of fine needle aspiration biopsy in thyroid nodules

      ea0014p385
    • Congenital hypothyroidism – results of a protocol implemented &br;1993–2006

      ea0014p386
    • Relationship of treated maternal hyperthyroidism &br;and perinatal outcome

      ea0014p387
    • Characteristics of locally advanced differentiated thyroid cancer in &br;a cohort of patients surgically treated at one oncological institution

      ea0014p388
    • Abnormal calcium metabolism as shown by the Ellsworth-Howard test and its relation to pseudohypoparathyroidism II

      ea0014p389
    • The role of non-calcemic analogs of vitamin D in differentiation of cultured rat bone marrow into osteoblast-like cells: age and sex differences

      ea0014p390
    • Mutual modulation of the vitamin D system and estrogen receptors in human bone cells in culture

      ea0014p391
    • Less-calcemic vitamin D analogs enhance biological responses and modulate responsiveness to gonadal steroids in skeletal tissues

      ea0014p392
    • The predictive role of body mass and composition upon bone mineral content: differences between premenopausal and postmenopausal women

      ea0014p393
    • Increased cortisol level in type 1 diabetic patient may lead decreasing of bone mineral density

      ea0014p394
    • Body fat concentration is a poor predictor of bone mineral content in hyperthyroid women

      ea0014p395
    • Vitamin D receptor gene polymorphisms: influence on bone metabolism in type 1 diabetic patients

      ea0014p396
    • Change in bone mass due to hyperthyroidism

      ea0014p397
    • Correlation between bone minerale density and bone turnover in delayed puberty

      ea0014p398
    • Prevalence of primary hyperparatiroidism in treated and untreated breast cancer

      ea0014p399
    • Relationship between antropometric and metabolic parameters and parathyroid hormone levels in women

      ea0014p400
    • Serum calcium levels and metabolic disturbances in obese women

      ea0014p401
    • Marginal periodontal pathology in patients with pituitary disorders

      ea0014p402
    • Tumor induced osteomalacia caused by haemangioma of the acetabular surface

      ea0014p403
    • Fracture risk in diabetic patients

      ea0014p404
    • Predictors of bone mineral density in women with primary hyperparathyroidism

      ea0014p405
    • Carotid intima media thickness and bone turnover in type 2 diabetic patients

      ea0014p406
    • Primary hyperparathyroidism is associated with an increased risk of vertebral fracture assessed by morphometric x-ray absorptiometry

      ea0014p407
    • Bone mineral density and bone markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid carcinoma

      ea0014p409
    • Bone mineral density in end-stage chronic kidney disease patients

      ea0014p410
    • Vitamin D receptor gene Bsm1 and Fok1 polymorphisms and indices of bone mass and bone turnover in healty young Turkish men and women

      ea0014p411
    • Parathyroid sonography in patients with normocalcemic primary hyperparathyroidism

      ea0014p412
    • Diagnostic role of GNAS1 mutation screening in patients with pseudohypoparathyroidism

      ea0014p413
    • CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulphate level and bone mineral density in postmenopausal women

      ea0014p414
    • Evaluation of diastolic function and its relationship with carotis intima media thickness and endothelial function in asymtomatic hyperparathyroid patients

      ea0014p415
    • Cinacalcet (Mimpara®, Amgen) is more effective than bisphosphonates at controlling hypercalcemia in patients with parathyroid carcinoma: a case study

      ea0014p416
    • Is there any relationship between the BsmI polymorphism in the vitamin D receptor gene and the occurrence of glucocorticoid-induced osteoporosis in asthmatic patients with long-term glucocorticoid treatment?

      ea0014p417
    • The relationship between the increased body mass index and the bone fracture prevalence in postmenopausal pollen allergic women

      ea0014p418
    • Decreased bone resorption in H1 histamine receptor antagonist treated allergic children

      ea0014p419
    • Changes of bone metabolism at the onset of puberty

      ea0014p420
    • Hypophosphatemic rickets and mutations in the PHEX gene

      ea0014p421
    • Changes of serum bone marker concentrations after effective therapy of patients with Cushing’s syndrome

      ea0014p422
    • Percutaneous ethanol injection therapy in patients with primary and secondary hyperparathyroidism

      ea0014p423
    • Juvenile osteoporosis in untreated GH-deficient patient – is treatment with GH replacement indicated? A clinical case report

      ea0014p424
    • Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism

      ea0014p425
    • Dehydroepiandrosterone and bone mineral density in elderly women

      ea0014p426
    • Bone mineral density and calcium deficiencies in adult patients with celiac disease

      ea0014p427
    • Implication of magnesium in calcium metabolism – a case report

      ea0014p428
    • Implication of magnesium in calcium metabolism – a case report

      ea0014p429
    • The effect of surgical cure of acromegaly on glycemic control in an elderly female patient suffering from type 2 diabetes – a case report

      ea0014p430
    • Endocrine function in a 48,XXYY adult

      ea0014p431
    • Simultaneous occurrence of multicentric medullary and papillary thyroid cancer: a case report

      ea0014p432
    • Simultaneous bilateral transperitoneal laparoscopic adrenalectomy (SBTLA)

      ea0014p433
    • Amyloid goitre: report of a case

      ea0014p434
    • Autoimmune polyglandular syndrome type I associated with motor focal epilepsy – a case report

      ea0014p435
    • Postpartum autoimmune hypophysitis, autoimmune hyperthyroidism and reversible hepatitis at a patient with partial empty sella

      ea0014p436
    • One case of sellar and suprasellar chordoma

      ea0014p437
    • Cutaneous modifications suggestive for Cushing’s syndrome induced by topical corticoid application

      ea0014p438
    • Clinical presentation of a patient with giant prolactinoma

      ea0014p439
    • Thyrotropin-producing pituitary adenoma discovered because of galactorrhea

      ea0014p440
    • An 8-year-old boy with seizures and hypokalemia due to a paraganglioma

      ea0014p441
    • Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery

      ea0014p442
    • Hyperthyroidism in molar pregnancy: rapid preoperative preparation by plasmapheresis and complete after evacuation

      ea0014p443
    • Finasteride treatment of premature androgenetic alopecia

      ea0014p444
    • Secondary adrenal failure and secondary amenorrhea due to hydromorphone treatment

      ea0014p445
    • Pseudophaeochromocytoma in Parkinson’s disease

      ea0014p446
    • Kallmann syndrome – deletion of the short arm of chromosome 8

      ea0014p447
    • Hyperprolactinemia in post-acute phase after severe TBI or SAH is mostly iatrogenic or due to physical stress

      ea0014p448
    • Rapid normalization of highly elevated serum chromogranin A after cessation of proton pump inhibitor therapy

      ea0014p449
    • Case of primary bilateral adrenal lymphoma

      ea0014p450
    • Familial hypocalciuric hypercalcemia: mutation in the calcium sensing receptor gene

      ea0014p451
    • Structured assessment of neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage – the interdisciplinary German database

      ea0014p452
    • Normal age-dependent values of serum insulin growth factor (IGF)–I: results from a healthy Italian population

      ea0014p453
    • Four cases of propylthiouracil–induced antineutrophil cytoplasmatic antibody-associated autoimmune syndrome

      ea0014p454
    • Difficult management of a thyrotoxic patient with abnormal liver function tests

      ea0014p455
    • Dermatological manifestations of the neuroendocrine cancer: a four cases report of primitive and metastatic Merkerl cell tumor

      ea0014p456
    • Retrospective analysis of diagnostic and treatment outcomes of primary aldosteronism

      ea0014p457
    • A case with hypercalcemia caused by hyperparathyroidism and multiple myeloma

      ea0014p458
    • Prostate specific antigen (PSA) in women with menstrual disturbances and mastopathy

      ea0014p459
    • Selected parameters of lipid metabolism in patients with Turner’s syndrome

      ea0014p460
    • Successive gestational hyperandrogenism with maternal virilization and female pseudohermaphroditism

      ea0014p461
    • Tetraploid/diploid mosaicism: case report of a 35-year-old woman

      ea0014p462
    • Genotype-phenotype correlation in Romanian patients with classical forms of 21-hydroxylase deficiency

      ea0014p463
    • Cushing’s syndrome in paediatric age – casuistic, evolution of investigation tests and treatment options in our institution throughout the last 20 years

      ea0014p464
    • Thyroidectomy as the last chance treatment for life threatening thyrotoxicosis: a case report

      ea0014p465
    • Insulinoma and gastrinoma in MEN 1: case report

      ea0014p466
    • Multiple endocrine dependent tumours in a dog patient without measurable endocrine consequences

      ea0014p467
    • Case report: Adrenal glands and stress: hypercortisolism in the course of urosepsis

      ea0014p468
    • Long-term experience and pharmacogenetic aspects of safety in 101 treatment-years with a long-acting formulation of testosterone undecanoate in substitution therapy of 66 hypogonadal men

      ea0014p469
    • Thyrotoxic hypokalemic periodic paralysis in two Caucasian females

      ea0014p470
    • Pseudophaeochrocytoma presenting with catatonia - a novel observation

      ea0014p471
    • Relapse of hyperthyroidism in Graves’ disease after long-term drug treatment

      ea0014p472
    • Bloch-sulzberger syndrome, hypothyroidism and a pituitary incidentaloma: a case report

      ea0014p473
    • Extreme obesity as an important obstacle in diagnosing a patient with MEN1

      ea0014p474
    • Six months physiological DHEA substitution in female adrenal failure: impact on quality of life and sexual parameters.

      ea0014p475
    • Central hypothyrodism and dyslipidemia induced by bexarotene in patients with cutaneous T-cell lymphoma

      ea0014p476
    • Thyroid dysplasia – 30 cases of lingual thyroids

      ea0014p477
    • Primary hyperparathyroidism during pregnancy – case report

      ea0014p478
    • Pituitary insufficiency after traumatic brain injury in southwest Hungary

      ea0014p479
    • Bartter syndrome – a case of secondary hyperaldosteronism

      ea0014p480
    • A Wellbeing patch induced Adrenal crisis

      ea0014p481
    • Antidepressants and elevated catecholamines

      ea0014p482
    • Myasthenia gravis and autoimmune Addison’s disease in a patient with thymoma

      ea0014p483
    • Severe hyperandrogenism during the entire course of pregnancy does not cause virilization of a female infant born

      ea0014p484
    • Regression of metastatic gastric carcinoid associated with atrophic gastritis and after octreotid treatment

      ea0014p485
    • Persistent fever after surgical removal of a craniopharyngioma: diagnosis pitfalls and therapeutic difficulties

      ea0014p486
    • Study of aldosterone secretion in patients with essential hypertension using a modified suppression test

      ea0014p487
    • Study of aldosterone secretion in patients with essential hypertension using a modified suppression test

      ea0014p488
    • GH-secreting adenomas may disappear with long-acting somatostatin analoque (octreotide-LAR) treatment

      ea0014p489
    • Adrenal rest tumours in 11-β hydroxylase deficiency

      ea0014p490
    • The possible role of genetics in severity of thyrotoxicosis

      ea0014p491
    • The challenge of managing thionamide induced agranulocytosis in a patient with Graves’ disease

      ea0014p492
    • Five-year treatment experience with metformin in polycystic ovary syndrome

      ea0014p493
    • Hand-Foot-Uterus syndrome in a patient with secondary amenorrhea: a rare case

      ea0014p494
    • Neonatal ventricular septal defect and late diagnosis of Turner syndrome

      ea0014p495
    • Interleukin-6-producing pheochromocytoma presenting with fever of unknown origin

      ea0014p496
    • Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene

      ea0014p497
    • A case of paraganglioma of glomus caroticum with lung metastasis

      ea0014p498
    • Intracranial giant sarcoma in an acromegalic patient after radiotherapy

      ea0014p499
    • Short stature and neurofibromatosis type 1 – issues of diagnosis

      ea0014p500
    • Paraneoplastic Cushing’s syndrome presenting as psychosis – case report

      ea0014p501
    • Endocrine tumour registry – tools for endocrine epidemiology

      ea0014p502
    • Tumour induced osteomalacia – a phosphaturic mesenchymal tumour

      ea0014p503
    • Unusual onset of Graves’ disease – case report

      ea0014p504
    • Growth hormone replacement therapy and metabolic parameters in adult-onset GH-deficiency: long-term effects.

      ea0014p505
    • Conventional glucocorticoid replacement therapy in patients with Addison’s disease: effects on metabolic and bone parameters

      ea0014p506
    • Gastric electrical stimulation in patients with severe diabetes mellitus associated gastroparesis – a cost benefit analysis

      ea0014p507
    • Levels of serum and salivary cortisol during low dose ACTH test in young adult-onset diabetes mellitus Type 1 patients

      ea0014p508
    • Long-term pegvisomant treatment in acromegaly

      ea0014p509
    • The assesment of life quality satisfaction in women with Turner’s syndrome

      ea0014p510
    • Pheochromocytoma in pediatric age

      ea0014p511
    • Ectopic localization of the pituitary bright spot in a patient with idiopathic central diabetes inspidus

      ea0014p512
    • Diabetes insipidus due to pituitary metastasis of breast cancer

      ea0014p513
    • Multicystic dysplastic kidney – a potential accelerant of complications in type I diabetes mellitus

      ea0014p514
    • MEN-1 phenotype without detectible MEN-1 mutation

      ea0014p515
    • Composite medullary and papillary tumor with mixed lymph node metastases

      ea0014p516
    • Management of endocrine syndrome in a patient with plurihormonal neuroendocrine tumour

      ea0014p517
    • Brown tumor in hyperparathyroidism – clinical case

      ea0014p518
    • Investigation of early atherosclerotic changes in acromegalic patients

      ea0014p519
    • Food preference, central serotoninergic activity, depression and insulin resistance in obese and lean healthy men: a pilot study

      ea0014p520
    • Somatic, body composition and psychological particularities in a group of untreated adult pituitary dwarves

      ea0014p521
    • L-thyroid hormone enhancement of antidepressant treatment in major depressive episode

      ea0014p522
    • Evaluation of cognitive functions by using P300 auditory event related potentials (ERPs) in amateur kickboxers: a preliminary study

      ea0014p523
    • Changes in hypothalamo-pituitary-testicular axis sensitivity in aging male

      ea0014p524
    • Glutamatergic neurons and synaptic contacts between glutamatergic axon terminals and chemically identified nerve cells in the rat hypothalamic suprachiasmatic nucleus

      ea0014p525
    • Laterality in the supraspinal innervation of the adrenal gland: a dual-virus tracer study

      ea0014p526
    • Prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients

      ea0014p527
    • Adulthood follow-up of a large number of patients with congenital morphological alteration of anterior and/or posterior pituitary lobes

      ea0014p528
    • Non-NMDA glutamate receptor antagonist injected into the mesencephalic dorsal raphe nucleus inhibits the suckling-induced prolactin release and administered into the lateral cerebral ventricle interferes with the diurnal fluctuations of plasma prolactin of male rats

      ea0014p529
    • The expression of the neuroprotective factor seladin-1 is up-regulated by thyroid hormones in human neuronal precursor cells, but not in mature neurons

      ea0014p530
    • Long-term evaluation of hypotalamic-pituitary-adrenal (HPA) axis in acromegalic patients during somatostatin analogs therapy and after successful surgery

      ea0014p531
    • Growth hormone deficiency and recombinant hGH (rhGH) replacement in children with idiopathic isolated GH deficiency: effects on the hypothalamus-pituitary-adrenal axis

      ea0014p532
    • Effects of glucocorticoid replacement on bone mass in women after long-term remission of Cushing’s syndrome

      ea0014p533
    • Factors influencing the rhythmic secretion of melatonin in human

      ea0014p534
    • Neurotropic profiles of androgens - mechanisms and targets

      ea0014p535
    • Age-related changes of circadian rhythmicity: relationship with melatonin.

      ea0014p536
    • Idiopathic isolated GH deficiency (IGHD) and combined pituitary hormone deficiency (CPHD) in Italy: genetic screening and clinical correlates

      ea0014p537
    • Increased intraovarian levels of noradrenaline and NGF precede the follicular changes in the rat ovary at the end of reproductive period

      ea0014p538
    • Incorporation and release of ³H-norepinephrine by granulosa cells: Novel functionality for endocrine cells

      ea0014p539
    • Treatment of Cushing’s disease by transsphenoidal pituitary microsurgery: prognosis factors and long-term follow-up

      ea0014p540
    • Ketoconazole before transsphenoidal surgery in Cushing’s disease patiens as a good alternative to glucocorticoids perioperatory treatment

      ea0014p541
    • Analysis of three different tests in the diagnosis of growth hormone deficit (GHD) in patients with severe cerebral trauma

      ea0014p542
    • Meningiomas in patients diagnosed with acromegaly: the report of two cases

      ea0014p543
    • Topoisomerase II alpha expression in pituitary tumours – preliminary results

      ea0014p544
    • Is there an endocrine explanation for persistent neuropsychological disabilities long after traumatic brain injury (TBI)?

      ea0014p545
    • ACTH and cortisol responses to ghrelin and DDAVP in patients with Cushing’s disease (CD)

      ea0014p546
    • Effect of treatment with somatostatin analogue on glucose homeostasis in patients with acromegaly

      ea0014p547
    • Effects of combined treatment with cabergoline and somatostatin analogues (SAA) on GH and IGF-I levels and tumor volume in patients with acromegaly not fully responsive to SAA

      ea0014p548
    • Macroprolactin: the clinically and diagnostically importance

      ea0014p549
    • OASIS: observational study on the international clinical practice for the treatment of recently diagnosed acromegalic patients

      ea0014p550
    • Comparison of basal ghrelin and leptin serum levels and after an oral glucose tolerance test in active and inactive acromegalic patients

      ea0014p551
    • Determinants of the acromegalic cardiomyopathy: a prospective, controlled study in 205 patients

      ea0014p552
    • Growing incidence of idiopathic isolated secondary adrenal insufficiency.

      ea0014p553
    • The role of fibrinogen and CRP in cardiovascular risk in patients with acromegaly

      ea0014p554
    • Evaluation of insulin sensitivity with euglycemic hyperinsulinemic clamp technique in non-obese patients with microprolactinoma

      ea0014p555
    • Evaluation of insulin sensitivity with euglycemic hyperinsulinemic clamp technique in non-obese patients with microprolactinoma

      ea0014p556
    • Comparative analysis of reactivity of macroprolactin in first and second-generation prolactin assays

      ea0014p557
    • Cabergoline treatment in Cushing’s disease: effect on hypertension, glucose intolerance and dyslipidemia.

      ea0014p558
    • Development and validation of a questionnaire to evaluate health-related quality of life in patients with Cushing’s syndrome

      ea0014p559
    • Differential expression of genes related to aggressiveness in non-functioning pituitary adenomas

      ea0014p560
    • Effects of CST-8, a synthetic cortistatin analogue, in humans

      ea0014p561
    • Prevalence of anterior pituitary dysfunction in patients following traumatic brain injury (TBI) in a German multi-centre screening program

      ea0014p562
    • Distribution of type 1 cannabinoid receptor (CB1) immunoreactive axons in the mouse hypothalamus

      ea0014p563
    • Immunohistochemistry of pure growth hormone-containing and mixed growth hormone/prolactin-containing pituitary adenomas

      ea0014p564
    • The effects of pasireotide (SOM230) on glucose metabolism and growth hormone (GH) nadir during oral glucose tolerance test (OGTT) in 12 patients with acromegaly from a Phase II study

      ea0014p565
    • Cerebrospinal fluid (CSF)/serum albumin ratio shows no alteration of the blood-brain barrier in patients with pituitary adenomas and high CSF levels of pituitary hormones

      ea0014p566
    • Medial cerebral artery occlusion 25 years after cranial radiation therapy in acromegaly

      ea0014p567
    • The hypothalamic-pituitary-adrenal axis in premenopausal females with psoriatic arthritis

      ea0014p568
    • Cortisol and dexamethasone exert different negative feedback action in humans

      ea0014p569
    • The role of vasopressin in the hypothalamo-pituitary-adrenal axis regulation during the perinatal period: paradoxical corticosterone elevation without an ACTH rise

      ea0014p570
    • Riluzole treatment does not affect growth hormone (GH) secretion in amyotrophic lateral sclerosis

      ea0014p571
    • Impairment of GH secretion by ghrelin stimulation test in primary hyperparathyroidism (PHP)

      ea0014p572
    • The influence of cabergoline treatment on seminal fluid

      ea0014p573
    • Fractionated stereotactic conformal radiotherapy for skull base benign tumours: an endocrinological follow-up

      ea0014p574
    • The GH releasing activity of ghrelin is insensitive to the negative growth hormone (GH) autofeedback in humans

      ea0014p575
    • Impaired GH secretion in women with HIV-related lipodystrophy

      ea0014p576
    • Midnight salivary cortisol vs. urinary free cortisol for the diagnosis of Cushing’s syndrome

      ea0014p577
    • Behavioural and biological effects of des-Gln14-ghrelin

      ea0014p578
    • Diagnostic accuracy of bilateral inferior petrosal sinus sampling performed following a combined stimulation with CRH and desmopressin

      ea0014p579
    • The empty sella syndrome – particularities of the clinical features depending on etiology

      ea0014p580
    • Effects of successful transsphenoidal surgery on cardiovascular function in elderly acromegalics

      ea0014p581
    • Clinicopathologic correlation in cases with macronodular hyperplasia

      ea0014p582
    • The endocrine and behavioural actions of neuromedine S

      ea0014p583
    • Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective cohort study

      ea0014p584
    • Genetic analysis of PROP1 gene in patients with childhood-onset combined pituitary hormone deficiency (CPHD)

      ea0014p585
    • The role of G-protein- and β-arrestin dependent signaling mechanisms in the tonic regulation of prolactin secretion

      ea0014p586
    • Secondary hypothalamic amenorrhea as the initial manifestation of HIV infection

      ea0014p587
    • Hypopituitary patients have an increased prevalence of cardiovascular risk factors

      ea0014p588
    • The evaluation of ghrelin concentration in patients treated for acromegaly and of ghrelin expression in pituitary somatotropinomas

      ea0014p589
    • Ghrelin, inhibits AMPK (AMP-dependent protein kinase), a regulator of cell proliferation and metabolism

      ea0014p590
    • Self-concept in patients with PCOS

      ea0014p591
    • Evaluation of hypotalamic-pituitary-gonadal (HPG) axis and GH-IGF-I axis in adult patients with celiac disease

      ea0014p592
    • The effects of salsolinol on the peripheral sympathetic activity of hypophysectomized, adrenalectomized and medullectomized rats

      ea0014p593
    • Cardiovascular risk and hypopituitarism: evaluation of the global cardiovascular absolute risk, using the individual score of the Progetto CUORE of the Istituto Superiore della Sanità

      ea0014p594
    • Traumatic brain injury (TBI) and lipid profile abnormalities: study 12 months after the brain injury

      ea0014p595
    • Traumatic brain injury (TBI) and lipid profile abnormalities: study 12 months after the brain injury

      ea0014p596
    • Does concealment of bad news stimulate the HPA or the SAS axis?

      ea0014p597
    • Non-dopaminergic neurons expressing individual enzymes of dopamine synthesis in the arcuate nucleus: development and functional significance

      ea0014p598
    • Impact of somatostatin analogs on the heart in acromegaly: a meta-analysis

      ea0014p599
    • Thyrotropinoma response to somatostatin receptor ligand (SRL) – key feature in preoperative treatment

      ea0014p600
    • Glucose resistance in acromegaly is reversible during somatostatin analogues treatment

      ea0014p601
    • Endocrine and neuro-ophtalmologic correlates of primary empty sella

      ea0014p602
    • Growth hormone deficiency in patients with acromegaly after ‘successful’ transsphenoidal surgery

      ea0014p603
    • Excess mortality in women with pituitary disease: results of a meta-analysis

      ea0014p604
    • Familial acromegaly – the role of the AIP gene

      ea0014p605
    • Validation of different insulin sensitivity indices in GH deficiency children using roc curve analysis

      ea0014p606
    • The transition phase in GHD patients and metabolic alterations: life span variations of insulin sensitivity?

      ea0014p607
    • Growth hormone deficiency in succesfully treated acromegalic patients is not protective from cardiac complications

      ea0014p608
    • Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource

      ea0014p609
    • A comparison between the efficacy and safety of pegvisomant to that of octreotide LAR in patients with acromegaly

      ea0014p610
    • Androtest: a structured interview for the screening of hypogonadism in patients with sexual dysfunction

      ea0014p611
    • Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction

      ea0014p612
    • Effect of hormone replacement therapy apart from growth hormone on the endothelial functions in patients with Sheehan’s syndrome

      ea0014p613
    • Family history of diabetes mellitus determines insulin sensitivity and beta cell dysfunction in polycystic ovary syndrome

      ea0014p614
    • Retinol-binding protein-4 in polycystic ovary synrome - relationship with obesity and androgen levels

      ea0014p615
    • Protein metabolism in a model of premature ovarian failure, Turner syndrome, and the impact of hormone replacement therapy

      ea0014p616
    • Differences in the onset of puberty in selected inbred mouse strains

      ea0014p617
    • The investigation of hypothalamo-pituitary-gonadal axis in patients with epilepsy

      ea0014p618
    • Varicocele sclerotherapy improves serum inhibin B levels and seminal parameters

      ea0014p619
    • LH receptor gene expression and splicing variants in marmoset (Callithrix jacchus) testis and adrenal gland at puberty

      ea0014p620
    • Protamine 1 and Protamine 2 sequence variants in teratozoospermia

      ea0014p621
    • Ghrelin effects on spontaneous and stimulated LH secretion in human males

      ea0014p622
    • Differential effects of two-week treatment with atorvastatin or elocalcitol, two RhoA/ROK signalling modulators, on erectile function and sildenafil responsiveness in spontaneously hypertensive rats

      ea0014p623
    • Testosterone regulates RhoA/Rho-kinase signalling in two distinct animal models of chemical diabetes

      ea0014p624
    • Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat

      ea0014p625
    • Androgenicity, androgen receptor polymorphism and pharmacogenetics

      ea0014p626
    • Characterization and functional role of an androgen-dependent PDE5 activity in bladder

      ea0014p627
    • Testosterone levels correlate positively with HDL cholesterol levels in men with Type 2 diabetes

      ea0014p628
    • Mutations of GnRH receptor and GPR54 in a cohort of patients with idiopathic hypogonadotropic hypogonadism

      ea0014p629
    • Assessment of non-enzymatic antioxidant profile of women on contraceptives

      ea0014p630
    • Hypothalamic-pituitary-gonadal axis responses of the male rats short and long time static magnetic fields (50 Hz) exposure

      ea0014p631
    • Adrenal rest tissue in gonads in 70 French patients with classical congenital adrenal hyperplasia (21 hydroxylase deficiency)

      ea0014p632
    • Three months exercise training improves cardiopulmonary functional capacity in polycystic ovary syndrome

      ea0014p633
    • Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in polycystic ovary syndrome

      ea0014p634
    • Age at menarche in relation to adult obesity

      ea0014p635
    • The multi-PDZ domain protein MUPP1: a scaffolding protein controlling the acrosome reaction in mammalian spermatozoa

      ea0014p636
    • Expression of the G-protein α-subunit gustducin in mammalian spermatozoa

      ea0014p637
    • Delayed puberty with extreme uterine hypotrophy: do not conclude too early to the absence of the uterus

      ea0014p638
    • Screening and treatment of gestational diabetes and impaired glucose tolerance in Georgia

      ea0014p639
    • The effects of cycloheximide, actinomycine D and indomethacin on progesterone release stimulated by PACAP 38 from cultured rat ovarian granulosa cells

      ea0014p640
    • XX-male syndrome: clinical, hormonal and molecular genetic findings in comparison to Klinefelter patients and normal men

      ea0014p641
    • Expansion of CD4⁺CD25⁺ regulatory T cells during murine pregnancy is not driven by pregnancy-associated hormones

      ea0014p642
    • The clinical outcomes of stimulation of ovulation in patients with idiopathic hypogonadotropic hypogonadism (IHH) caused by mutations of GnRH receptor

      ea0014p643
    • Atherogenic indexes in women with premature ovarian failure-POF

      ea0014p644
    • Effect of age and testosterone on sleep related erections

      ea0014p645
    • Hormonal and seminal parameters in patients with testicular neoplasia or lymphoproliferative disorders: two year follow up

      ea0014p646
    • Immunohistochemical evaluation of ghrelin expression in polycystic ovaries in patients with PCOS.

      ea0014p647
    • Ovarian hyperstimulation syndrome during IVF induction revealing a gonadotroph adenoma

      ea0014p648
    • Insulin levels and lipid profile in lean women with polycystic ovary syndrome

      ea0014p649
    • Demonstration of estrogen receptor–β in human gonadotropin-releasing hormone neurons

      ea0014p650
    • Asymmetric dimethylarginine levels and carotid intima media thickness in patients with polycystic ovary syndrome

      ea0014p651
    • Ghrelin levels in obese patients with polycistic ovary syndrome

      ea0014p652
    • Ghrelin levels in lean patients with polycistic ovary syndrome

      ea0014p653
    • Adrenal morphology on CT-scan in patients with congenital adrenal hyperplasia

      ea0014p654
    • Anti-oxidant activity of seminal plasma in fertile and infertile men

      ea0014p655
    • Reproductive health of women born to bromocriptine-treated mothers

      ea0014p656
    • The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

      ea0014p657
    • The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

      ea0014p658
    • The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

      ea0014p659
    • The difference in the level of lipids, CRP, androgens and prolactins between PCOS women with metabolic syndrome and PCOS women without metabolic syndrome

      ea0014p660
    • Expression of p63 and Notch system in the rat testis and vaso-epididymal system during postnatal development

      ea0014p661
    • Transcripts expressed in the mouse testis during sex-determining period

      ea0014p662